ArticleFrontiers in bioengineering and biotechnology2022

Plant production of high affinity nanobodies that block SARS-CoV-2 spike protein binding with its receptor, human angiotensin converting enzyme.

Marco Pitino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.